[{"address1": "110 Allen Road", "address2": "2nd Floor", "city": "Basking Ridge", "state": "NJ", "zip": "07920", "country": "United States", "phone": "908 842 0100", "website": "https://www.lisata.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.", "fullTimeEmployees": 26, "companyOfficers": [{"maxAge": 1, "name": "Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D.", "age": 68, "title": "President, CEO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 1121095, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Nisco", "age": 53, "title": "Senior VP of Finance, Treasurer, CAO & Principal Financial and Accounting Officer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 472688, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kristen K. Buck M.D.", "age": 50, "title": "Executive VP of R&D and Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 905342, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tariq  Imam", "age": 41, "title": "Senior VP of Business Development & Operations and General Counsel", "yearBorn": 1984, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gregory S. Berkin", "title": "Chief Information & Data Protection Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John D. Menditto", "title": "Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William K. Sietsema Ph.D.", "age": 68, "title": "Vice President of Global Regulatory Affairs", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 350554, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.625, "open": 4.63, "dayLow": 4.55, "dayHigh": 4.72, "regularMarketPreviousClose": 4.625, "regularMarketOpen": 4.63, "regularMarketDayLow": 4.55, "regularMarketDayHigh": 4.72, "payoutRatio": 0.0, "beta": 1.114, "forwardPE": -4.517073, "volume": 77661, "regularMarketVolume": 77661, "averageVolume": 173429, "averageVolume10days": 689310, "averageDailyVolume10Day": 689310, "bid": 4.54, "ask": 4.67, "bidSize": 1, "askSize": 1, "marketCap": 40840000, "fiftyTwoWeekLow": 1.81, "fiftyTwoWeekHigh": 4.89, "allTimeHigh": 637500.0, "allTimeLow": 1.81, "priceToSalesTrailing12Months": 38.168224, "fiftyDayAverage": 2.3914, "twoHundredDayAverage": 2.4569, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 21587994, "profitMargins": 0.0, "floatShares": 7064172, "sharesOutstanding": 8820733, "sharesShort": 7804, "sharesShortPriorMonth": 15440, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.00090000004, "heldPercentInsiders": 0.19674999, "heldPercentInstitutions": 0.08392, "shortRatio": 0.2, "shortPercentOfFloat": 0.0011, "impliedSharesOutstanding": 8820734, "bookValue": 1.984, "priceToBook": 2.3336694, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -18242000, "trailingEps": -2.13, "forwardEps": -1.025, "lastSplitFactor": "1:15", "lastSplitDate": 1663200000, "enterpriseToRevenue": 20.176, "enterpriseToEbitda": -1.084, "52WeekChange": 0.79457366, "SandP52WeekChange": 0.1575526, "quoteType": "EQUITY", "currentPrice": 4.63, "targetHighPrice": 15.0, "targetLowPrice": 4.0, "targetMeanPrice": 11.33333, "targetMedianPrice": 15.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 18998000, "totalCashPerShare": 2.154, "ebitda": -19907000, "totalDebt": 0, "quickRatio": 4.422, "currentRatio": 4.723, "totalRevenue": 1070000, "revenuePerShare": 0.125, "returnOnAssets": -0.41861, "returnOnEquity": -0.72167, "grossProfits": 1070000, "freeCashflow": -11452375, "operatingCashflow": -17228000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -18.765419, "financialCurrency": "USD", "symbol": "LSTA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_338272", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 0.10811058, "regularMarketPrice": 4.63, "shortName": "Lisata Therapeutics, Inc.", "longName": "Lisata Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1769809723, "regularMarketTime": 1769806802, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 920298600000, "postMarketChangePercent": 0.21597736, "postMarketPrice": 4.64, "postMarketChange": 0.009999752, "regularMarketChange": 0.0050001144, "regularMarketDayRange": "4.55 - 4.72", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 173429, "fiftyTwoWeekLowChange": 2.8200002, "fiftyTwoWeekLowChangePercent": 1.5580112, "fiftyTwoWeekRange": "1.81 - 4.89", "fiftyTwoWeekHighChange": -0.25999975, "fiftyTwoWeekHighChangePercent": -0.053169686, "fiftyTwoWeekChangePercent": 79.45737, "earningsTimestamp": 1772139600, "earningsTimestampStart": 1772139600, "earningsTimestampEnd": 1772139600, "earningsCallTimestampStart": 1762464600, "earningsCallTimestampEnd": 1762464600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.13, "epsForward": -1.025, "epsCurrentYear": -2.325, "priceEpsCurrentYear": -1.9913979, "fiftyDayAverageChange": 2.2386, "fiftyDayAverageChangePercent": 0.93610436, "twoHundredDayAverageChange": 2.1731002, "twoHundredDayAverageChangePercent": 0.8844887, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Caladrius Biosciences, Inc.", "nameChangeDate": "2026-01-30", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "displayName": "Lisata Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]